Copyright © Philip M. Parker, INSEAD. Terms of Use.
| Domain | Definition |
Health | Comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the U.S. and in other countries. (references) |
Source: compiled by the editor from various references; see credits. | |
Hexadecimal (or equivalents, 770AD-1900s) (references)43 4C 49 4E 49 43 41 4C 54 52 49 41 4C 53 2C 50 48 41 53 45 49 49 49 |
| Leonardo da Vinci (1452-1519; backwards) (references)
|
Binary Code (1918-1938, probably earlier) (references)01000011 01001100 01001001 01001110 01001001 01000011 01000001 01001100 00100000 01010100 01010010 01001001 01000001 01001100 01010011 00101100 00100000 01010000 01001000 01000001 01010011 01000101 00100000 01001001 01001001 01001001 |
HTML Code (1990) (references)C L I N I C A L   T R I A L S ,   P H A S E   I I I |
ISO 10646 (1991-1993) (references)0043 004C 0049 004E 0049 0043 0041 004C 0054 0052 0049 0041 004C 0053 002C 0050 0048 0041 0053 0045 0049 0049 0049 |
Encryption (beginner's substitution cypher): (references)3746434843373546254524335465314250423553392434343 |
| 1. Orthography 2. Bibliography |
Copyright © Philip M. Parker, INSEAD. Terms of Use.
